Logo image
A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999-2015
Journal article   Open access   Peer reviewed

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999-2015

James Studnicki, Donna J Harrison, Tessa Longbons, Ingrid Skop, David C Reardon, John W Fisher, Maka M Tsulukidze and Christopher Craver
Health services research and managerial epidemiology, Vol.8
11-01-2021
PMID: 34778493

Abstract

Health Care Sciences & Services Health Policy & Services Life Sciences & Biomedicine Science & Technology
Introduction Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures. Objective To complete the first longitudinal cohort study of postabortion emergency room use following chemical and surgical abortions. Methods A population-based longitudinal cohort study of 423 000 confirmed induced abortions and 121,283 subsequent ER visits occurring within 30 days of the procedure, in the years 1999-2015, to Medicaid-eligible women over 13 years of age with at least one pregnancy outcome, in the 17 states which provided public funding for abortion. Results ER visits are at greater risk to occur following a chemical rather than a surgical abortion: all ER visits (OR 1.22, CL 1.19-1.24); miscoded spontaneous (OR 1.88, CL 1.81-1.96); and abortion-related (OR 1.53, CL 1.49-1.58). ER visit rates per 1000 abortions grew faster for chemical abortions, and by 2015, chemical versus surgical rates were 354.8 versus 357.9 for all ER visits; 31.5 versus 8.6 for miscoded spontaneous abortion visits; and 51.7 versus 22.0 for abortion-related visits. Abortion-related visits as a percent of total visits are twice as high for chemical abortions, reaching 14.6% by 2015. Miscoded spontaneous abortion visits as a percent of total visits are nearly 4 times as high for chemical abortions, reaching 8.9% of total visits and 60.9% of abortion-related visits by 2015. Conclusion The incidence and per-abortion rate of ER visits following any induced abortion are growing, but chemical abortion is consistently and progressively associated with more postabortion ER visit morbidity than surgical abortion. There is also a distinct trend of a growing number of women miscoded as receiving treatment for spontaneous abortion in the ER following a chemical abortion.
pdf
Tsulukidze-Craver-Fisher-Reardon-Skop-Longbons-Harrison-Studnicki1.87 MBDownloadView
CC BY-NC V4.0 Open Access
url
https://journals.sagepub.com/doi/pdf/10.1177/23333928211053965View
Published (Version of record)
url
https://doi.org/10.1177/23333928211053965View
Published (Version of record) Open

Related links

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality
Logo image